,Rank,NCTId,Condition,BriefTitle,InterventionName
0,1,NCT01589549,Acute GVH Disease,Mesenchymal Stromal Cells for Acute Graft Versus Host Disease,Mesenchymal stromal cell therapy
1,2,NCT02387151,Rejection|Graft Loss,Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,mesenchymal stromal cells
2,3,NCT03509870,Diabetic Foot Ulcer,Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds,mesenchymal stromal cells
3,4,NCT04447833,"ARDS, Human|COVID",Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Mesenchymal Stromal Stem Cells - KI-MSC-PL-205
4,5,NCT02057965,Renal Transplant Rejection|Fibrosis,Mesenchymal Stromal Cell Therapy in Renal Recipients,Mesenchymal Stromal Cells
5,6,NCT01090817,Crohn Disease,An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease,Mesenchymal stromal cells (MSC) for infusion
6,7,NCT01522716,Graft-Versus-Host Disease,Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease,Mesenchymal stromal cells
7,8,NCT02097641,"Respiratory Distress Syndrome, Adult",Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START),Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells|Plasma-Lyte A
8,9,NCT02150551,Inflammatory Bowel Diseases,Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease,Allogeneic bone marrow-derived mesenchymal stromal cells
9,10,NCT02012153,Kidney Transplant Rejection,Mesenchymal Stromal Cells in Kidney Transplant Recipients,Mesenchymal Stromal Cells
10,11,NCT03042572,Peripheral Arterial Disease|Cardiovascular Diseases|Vascular Diseases,Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs,Allogeneic Mesenchymal Stromal Cell|Placebo
11,12,NCT03818854,"Respiratory Distress Syndrome, Adult",Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome,Human Mesenchymal Stromal Cells|Cell Reconstitution Media
12,13,NCT02323789,Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal stromal cells
13,14,NCT02032446,Hematologic Malignancies,Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease,UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)
14,15,NCT03461458,Degenerative Disc Disease,"Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease",Autologous Adipose-Derived Mesenchymal Stromal Cells
15,16,NCT03478215,Renal Transplantation|Mesenchymal Stem Cells,Mesenchymal Stromal Cells in Living Donor Kidney Transplantation,Mesenchymal Stromal Stem Cells (MSCs) Infusion|Normal Saline (Placebo) Infusion
16,17,NCT05286255,COVID-19 Pneumonia|Viral Pneumonia,Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias,Allogeneic Mesenchymal Stromal Cells
17,18,NCT00644410,Congestive Heart Failure,Autologous Mesenchymal Stromal Cell Therapy in Heart Failure,Mesenchymal stromal cell|Saline
18,19,NCT03268603,ALS|Amyotrophic Lateral Sclerosis,Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS),Autologous Adipose-derived Mesenchymal Stromal Cells
19,20,NCT01061099,Osteogenesis Imperfecta Type II|Osteogenesis Imperfecta Type III,Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta,Mesenchymal Stromal Cells
20,21,NCT01764100,Graft vs Host Disease,Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD),Mesenchymal stromal cells
21,22,NCT02215811,"Acute Respiratory Distress Syndrome, Adult",Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells,Mesenchymal stromal cells
22,23,NCT02291770,Chronic Graft-Versus-Host Disease,Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells,Mesenchymal Stromal Cells
23,24,NCT04445454,Coronavirus Infection,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Mesenchymal stromal cells
24,25,NCT02814864,Pelvic Radiation Therapy|Radiation-induced Hemorrhagic Cystitis,"Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",Mesenchymal Stromal Cell (MSC) injections
25,26,NCT03211793,Systemic Sclerosis|Digital Ulcer,Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis,Mesenchymal stromal cells|Placebo
26,27,NCT02805855,"Osteoarthritis, Knee",Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis,Autologous Adipose-Derived Mesenchymal Stromal Cells
27,28,NCT04626583,Mesenchymal Stromal Cells|Cornea|Safety|Corneal Defect,Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells,Allogeneic MSC
28,29,NCT04466098,Acute Respiratory Distress Syndrome|ARDS (Moderate or Severe)|COVID-19 Pneumonia,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),Mesenchymal stromal cells|Placebo
29,30,NCT03233074,Myelodysplastic Syndromes|Acute Myeloid Leukemia|Cardio-vascular Surgery,Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors,Bone marrow analyses
30,31,NCT04345601,Sars-CoV2|Acute Respiratory Distress Syndrome|COVID-19,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),Mesenchymal Stromal Cells|Supportive Care
31,32,NCT01038596,Osteoarthritis,Mesenchymal Stromal Cells and Osteoarthritis,
32,33,NCT04356287,"Sclerosis, Systemic|Mesenchymal Stem Cells",Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis,UCMSC|Placebo
33,34,NCT04549285,Multisystem Inflammatory Syndrome in Children,Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome,Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs)
34,35,NCT04348461,COVID|Respiratory Distress Syndrome,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells
35,36,NCT03608631,KRAS NP_004976.2:p.G12D|Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8,iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation,Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA
36,37,NCT03014219,Perianal Fistula,Phase 1 Crohn's Pediatric Sub-study of MSC AFP,Only 1 arm: treatment with MSC-AFP
37,38,NCT04236479,Congenital Heart Disease (CHD),Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP),BM-MSC
38,39,NCT01659762,Crohn's Disease,A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.,autologous mesenchymal stromal cell
39,40,NCT02646007,Kienböck's Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease,BM-MSC transplantation
40,41,NCT04255147,Bronchopulmonary Dysplasia,Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia,Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells
41,42,NCT02580695,Osteoarthritis,A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis,umbilical-cord mesenchymal stromal cells|Hyaluronic Acid
42,43,NCT01175655,Bronchiolitis Obliterans|Lung Transplantation,A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation,MSC
43,44,NCT02565459,Chronic Renal Failure,MSC and Kidney Transplant Tolerance (Phase A),Mesenchymal Stromal Cells
44,45,NCT05061030,Type1diabetes,Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents,the ATMP Protrans
45,46,NCT03973827,Type1diabetes,Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans
46,47,NCT00957931,Sickle Cell Disease|Thalassemia|Diamond-Blackfan Anemia,"Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs",Bone marrow transplantation|Mesenchymal Stromal Cells
47,48,NCT03917797,"Lupus Erythematosus, Systemic|Lupus Glomerulonephritis",Mesenchymal Stromal Cells (MSC´s) in Renal Lupus,MSC treatment|Standard of Care|Placebo
48,49,NCT04467047,COVID-19|Sars-CoV2,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,Mesenchymal Stromal Cells infusion
49,50,NCT04615429,Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,Mesenchymal stromal cells|Placebo
50,51,NCT01872624,Pulmonary Emphysema,Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema,Bronchoscopy
51,52,NCT02421484,Septic Shock,Cellular Immunotherapy for Septic Shock: A Phase I Trial,Allogeneic mesenchymal stromal cells
52,53,NCT04328714,Acute Leukemia|Myelodysplastic Syndromes,Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease,Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
53,54,NCT01742260,Surgically-Created Resection Cavity,Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials,Repair of cranial defects by tissue engineering
54,55,NCT05035862,Asthma,Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma,Albuterol Sulfate|Interferon gamma-primed mesenchymal stromal cells (MSCs)|Prednisone
55,56,NCT02230514,Atrophic Nonunion of Fracture,Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones,XCEL-MT-OSTEO-ALPHA|autologous iliac crest|Surgery
56,57,NCT04361942,COVID-19 Pneumonia,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Mesenchymal Stromal Cells|Placebo
57,58,NCT02260375,Liver Transplant Rejection,MSC Therapy in Liver Transplantation,Mesenchymal Stromal Cells
58,59,NCT02495766,Relapsing-Remitting Multiple Sclerosis|Secondary Progressive Multiple Sclerosis,Autologous Mesenchymal Stromal Cells for Multiple Sclerosis,XCEL-MC-ALPHA|Placebo
59,60,NCT02384018,Chronic Pancreatitis|Diabetes,Mesenchymal Stem Cell and Islet Co-transplantation,autologous mesenchymal stromal cell
60,61,NCT03298399,Sickle Cell Disease,Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease,Autologous MSCs|Autologous MSCs|Autologous MSCs
61,62,NCT02943486,"Foot Ulcer, Diabetic",Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2,dac-MSCs|MSCs|Fitostimoline
62,63,NCT04089579,Autism|Autism Spectrum Disorder,hCT-MSC in Children With Autism Spectrum Disorder,Cord Tissue Mesenchymal Stromal Cells|Placebo Infusion
63,64,NCT05204329,Mesenchymal Stromal Cells|Cornea|Corneal Defect|Corneal Epithelium Defect,Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease,MSC Secretome Eye Drops
64,65,NCT03449069,Fistula in Ano|Crohn Disease,Pediatric MSC-AFP Sub-study for Crohn's Fistula,MSC-AFP
65,66,NCT04918706,Pulmonary Emphysema|Mesenchymal Stromal Cells,Allogeneic MSC Treatment for Pulmonary Emphysema,Allogeneic MSC|Placebo
66,67,NCT02807389,Surgical Leak Fistula,Stem Cell Fistula Plug in Post Surgical Leak Fistulas,MSC Fistula Plug
67,68,NCT02589119,Perianal Fistula|Cryptoglandular Perianal Fistula,Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP),MSC-AFP
68,69,NCT03220243,Fistula Vagina|Crohn Disease,Stem Cell Coated Fistula Plug in Patients With Crohn's RVF,MSC-AFP
69,70,NCT01849237,Septic Shock|Nonchemotherapy Drug-induced Neutropenia|Neutropenia After Chemotherapy in Oncohematological Patients|Neutropenia in Patients With Aplastic Anemia,Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia,Mesenchymal stromal cells|Standard therapy of septic shock
70,71,NCT02359929,Graft Versus Host Disease|Acute Graft Versus Host Disease|Chronic Graft Versus Host Disease,BMT Autologous MSCs for GvHD,Autologous mesenchymal stromal cells (MSCs)
71,72,NCT04714801,Lung Transplant Rejection,Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation,adipose derived mesenchymal stromal cells|Saline
72,73,NCT01306513,Emphysema,Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema,autologous bone marrow derived mesenchymal stromal cells
73,74,NCT04034316,Nephrotic Syndrome in Children|Steroid-Dependent Nephrotic Syndrome|Idiopathic Nephrotic Syndrome,Reduce Immunosuppression With Atmp in NS ChildrEn,Cord-blood mesenchymal stromal cells
74,75,NCT04675359,Knee Osteoarthritis|Chondropathy,Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment,Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint
75,76,NCT01449032,Chronic Ischemic Heart Disease,MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial),MSC|Saline
76,77,NCT04333368,Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Umbilical cord Wharton's jelly-derived human|NaCl 0.9%
77,78,NCT02055625,Graft -Versus-host-disease,Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease,Mesenchymal stromal cells
78,79,NCT04525378,"Covid19|ARDS, Human",MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,Mesenchymal stromal cell-based therapy
79,80,NCT03522545,Treatment-resistant Bipolar Depression,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)|Placebo
80,81,NCT04400032,Acute Respiratory Distress Syndrome|Covid19,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,Mesenchymal Stromal Cells
81,82,NCT03810521,"Osteoarthritis, Knee",Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis,umbilical cord derived-mesenchymal stromal cells
82,83,NCT04711200,Epidermal Necrolysis|Lyell Syndrome|Toxic Epidermal Necrolysis|Overlap Syndrome|Mesenchymal Stromal Cells|Adipose Derived Stromal Cells,LYell SYndrome MEsenchymal Stromal Cells Treatment,Adipose derived stromal cells intravenously injected
83,84,NCT05283317,Sepsis|Septic Shock,Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock,Mesenchymal stem cells
84,85,NCT05465096,Hip Osteoarthritis|Hip Disease,Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.,Micro-fragmented adipose tissue injection
85,86,NCT03007576,"Osteoarthritis,Knee",Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem),RegStem
86,87,NCT04290182,Hoarseness|Dysphonia|Aphonia|Vocal Fold; Scar,A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring,MSC-KI-PL-204
87,88,NCT04399889,COVID|Corona Virus Infection|COVID19,hCT-MSCs for COVID19 ARDS,Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.|Placebo
88,89,NCT03828123,"Motor Neuron Disease, Amyotrophic Lateral Sclerosis",Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis,Suspension of human autologous MSC 3P in 1.5 ml
89,90,NCT04744116,Hematopoietic and Lymphoid Cell Neoplasm|Steroid Refractory Graft Versus Host Disease,Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease,Cellular Therapy|Ruxolitinib
90,91,NCT04489732,Xerostomia Following Radiotherapy,MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer,"Autologous bone-marrow derived, interferon gamma stimulated mesenchymal stromal cells"
91,92,NCT02709343,Chronic Lung Allograft Dysfunction (CLAD),Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction,Bone-marrow derived MSCs|Placebo
92,93,NCT03504241,Kidney Transplantation|Renal Transplantation|Renal Transplant Recipient,Tolerance by Engaging Antigen During Cellular Homeostasis,Donor-derived Mesenchymal Stromal Cells|alemtuzumab|belatacept|sirolimus|mycophenolate mofetil|mycophenolate acid|prednisone
93,94,NCT05456243,Kidney Transplant,Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients,Low dose adipose tissue derived mesenchymal stromal cells (A-MSC)|High dose adipose tissue derived mesenchymal stromal cells (A-MSC)
94,95,NCT04366830,Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",Remestemcel-L
95,96,NCT04435249,Bronchopleural Fistula,ENgineered Tissue Repair of BronchopleUral fiSTula,BPF-001
96,97,NCT04325594,Chronic Heart Failure|Non-ischemic Cardiomyopathy|Non-ischemic Dilated Cardiomyopathy,The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Chronic Heart Failure of Non-ischemic Etiology,Cardiac catheterization|Intracoronary administration of the umbilical cord-derived mesenchymal stromal cells
97,98,NCT04971161,Skin Ulcer Venous Stasis Chronic,Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb),allo-APZ2-CVU|Placebo
98,99,NCT04896853,COVID-19 Acute Respiratory Distress Syndrome,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans®,ProTrans®
99,100,NCT03209700,Perianal Fistula|Cryptoglandular Perianal Fistula|Crohn's Perianal Fistula,Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas,MSC-AFP
100,101,NCT03406585,Type1 Diabetes Mellitus,Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans: Allogeneic transplantation with WJMSCs|Placebos
101,102,NCT05464381,Epidermolysis Bullosa,"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)",allo-APZ2-OTS|Placebo
102,103,NCT01860417,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),Allogenic Mesenchymal Stromal Cells|Mepivacaine
103,104,NCT02336230,Grade B aGVHD|Grade C aGVHD|Grade D aGVHD,"A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",remestemcel-L
104,105,NCT02997878,"Cholangitis, Sclerosing|Hepatitis, Autoimmune","A Single-arm,Phase IIa,Safety and Efficacy Trial of Selected MSCs in the Treatment of Patients With PSC & AiH",Orbcel-C
105,106,NCT01586312,"Osteoarthritis, Knee|Arthritis of Knee|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,Allogenic mesenchymal stromal cells injection|Hyaluronic Acid
106,107,NCT04869397,Covid19,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,Allogeneic Wharton's jelly-MSCs (WJ-MSC)|Placebo
107,108,NCT03901235,Efficacy and Safety,MSC Intratissular Injection in Crohn Disease Patients,Mesenchymal Stromal Cells
108,109,NCT01922908,Ischemic Stroke,Mesenchymal Stromal Cells for Ischemic Stroke,MSC Infusion|Placebo Comparator
109,110,NCT04341610,Respiratory Tract Diseases,ASC Therapy for Patients With Severe Respiratory COVID-19,Stem Cell Product
110,111,NCT02270307,Leukemia|Multiple Myeloma,MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis,Cyclophosphamide|Mesenchymal stromal cells
111,112,NCT02033525,Chronic Meniscal Injury,Mesenchymal Stromal Cells for Degenerative Meniscus Injury,XCEL-M-ALPHA and standard rehabilitation|Rehabilitation
112,113,NCT04018729,Chronic Obstructive Pulmonary Disease Severe,Cell Therapy Associated With Endobronchial Valve,Zephyr Endobronchial Valve|Marrow-derived mesenchymal stromal cell
113,114,NCT05433298,COVID-19 Pneumonia|COVID-19,Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.,Mesenchymal stem cell|Placebo
114,115,NCT05095532,Chronic Pancreatitis|Mesenchymal Stem Cells,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT,Bone marrow-derived mesenchymal stem cells|Placebo
115,116,NCT02585622,Diabetic Kidney Disease,NEPHSTROM for Diabetic Kidney Disease,Mesenchymal Stromal Cells|Placebo
116,117,NCT02165904,Spinal Cord Injury,Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI,Adult Autologous Mesenchymal Bone Marrow Cell
117,118,NCT02603744,Premature Ovarian Failure,Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF),Intraovarian injection of Adipose derived Stromal cells (ADSCs)
118,119,NCT04815213,Premature Ovarian Failure,The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans,expanded autologous bone marrow derived MSC
119,120,NCT03015623,Acute Kidney Injury,A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy,SBI-101|Sham
120,121,NCT03651791,Ischemic Heart Disease,In Vivo Tracking of USPIO Labeled MSC in the Heart,USPIO labeled MSC injection
121,122,NCT05490173,"Premature Birth|Extreme Prematurity|Preterm Intraventricular Hemorrhage|Hypoxia-Ischemia, Cerebral|Neurodevelopmental Disorders",The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants,Exosomes derived from mesenchymal stromal cells (MSCs)
122,123,NCT05131412,Pneumonia|Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation,
123,124,NCT04445220,COVID-19|Acute Kidney Injury|Sepsis,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,SBI-101
124,125,NCT04210440,Hip Necrosis|Hip Injuries,The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression,Core decompression procedure
125,126,NCT04456439,Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19),"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",Remestemcel-L|Hydrocortisone|Diphenhydramine
126,127,NCT04629833,Steroid-refractory Acute Graft-versus-host Disease,Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy,MC0518|BAT
127,128,NCT02838069,Osteoarthritis,A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis,Injection (2x106 ASC/5ml).|Injection (10x106 ASC/5ml).|Placebo
128,129,NCT04371393,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,MSCs in COVID-19 ARDS,Remestemcel-L|Placebo
129,130,NCT02382874,Focal Segmental Glomerulosclerosis,Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis),Intravenous injection
130,131,NCT02448849,Bone Fracture,Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment,Percutaneous injection|Percutaneous injection
131,132,NCT04397471,Healthy Volunteers for Bone Marrow Donation,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,Bone Marrow Harvest
132,133,NCT04294290,Autism Spectrum Disorder,Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder,hCT-MSC infusion
133,134,NCT03608579,"Osteoarthritis, Hip",Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA,Autologous Adipose Derived Mesenchymal Stromal Cells
134,135,NCT01915927,Perianal Crohn's Disease,Stem Cell Fistula Plug in Perianal Crohn's Disease,MSC-AFP
135,136,NCT02145923,Neutropenic Enterocolitis|Myeloablative Chemotherapy Induced Bone Marrow Aplasia,Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis,Peripheral blood stem cell mobilisation and collection|High-dose chemotherapy|Bone marrow derived allogeneic MMSCs infusion|Autologous peripheral blood stem cells infusion
136,137,NCT03473301,Cerebral Palsy,A Study of UCB and MSCs in Children With CP: ACCeNT-CP,Infusion of allogeneic umbilical cord blood|Infusion of MSCs
137,138,NCT01909154,Spinal Cord Injury,Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia,Mesenchymal stromal cell therapy
138,139,NCT04484077,Autism Spectrum Disorder|Autism,hCT-MSC Infusion in Adults With Autism Spectrum Disorder,hCT-MSC
139,140,NCT02829216,Abnormal Hematopoiesis|Allogenic Disease|Graft vs Host Disease,Graft-versus-host Disease Associated Myelosuppression,
140,141,NCT02351011,Osteoarthritis of Knee,Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA,1 x 10^6 MSCs|10 x 10^6 MSCs|50 x 10^6 MSCs
141,142,NCT00260338,Myocardial Ischemia|Coronary Heart Disease,Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia,stem cell
142,143,NCT02181478,Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndromes|Myelofibrosis|Relapsed Non-Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Lymphoid Malignancies|Chronic Myelogenous Leukemia,Intra-Osseous Co-Transplant of UCB and hMSC,cyclophosphamide|fludarabine phosphate|total-body irradiation|cyclosporine|mycophenolate mofetil|umbilical cord blood transplantation|mesenchymal stem cell transplantation
143,144,NCT03389919,Mesenchymal Stem Cell Transplantation,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,MSC administration (intraosseal)
144,145,NCT02630836,Femoral Neck Fracture,Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture,XCEL-MT-OSTEO-BETA|Surgical treatment
145,146,NCT03099239,Autism|Autism Spectrum Disorder|ASD,hCT-MSCs for Children With Autism Spectrum Disorder (ASD),hCT-MSC infusion
146,147,NCT01585857,Osteoarthritis,ADIPOA - Clinical Study,Autologous adipose derived stem cells administrated for intra-articular use|Autologous adipose derived stem cells administrated for intra-articular use
147,148,NCT03113747,Second- or Third-degree Burns,Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs),ALLO-ASCs
148,149,NCT05491135,Acute Liver Failure,Hepatocyte Microbeads for Acute Liver Failure,HMB002
149,150,NCT02706132,Liver Transplantation,Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation,Mesenchymal Stem Cells(MSCs)
150,151,NCT04545307,Pulp Necroses|Apical Periodontitis,Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis,Allogenic transplant of BM-MSC in a root canal from patients with immature apexes and pulpar necrosis and apical periodontitis
151,152,NCT04007081,Xerostomia|Head and Neck Cancer,Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia,Bone Marrow Aspiration|Ultrasound Imaging of Salivary Glands|Salivary Assay|Quality of Life Instruments
152,153,NCT01686139,Type I Diabetes Mellitus With Ulcer|Type II Diabetes Mellitus With Ulcer,Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers,ABMD-MSC
153,154,NCT01275612,Solid Tumors|Acute Kidney Injury,Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Mesenchymal stromal cell infusion
154,155,NCT05333029,Graft Versus Host Disease,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,Allogeneic mesenchymal stromal cells (MSCs)|Extracorporeal photopheresis (ECP)
155,156,NCT03673748,Lupus Nephritis|Lupus Erythematosus,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,Mesenchymal stromal cells (MSC)|Placebo
156,157,NCT02274428,Mesenchymal Stromal Cells,Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage,pneumostem
157,158,NCT03635450,Moderate to Severe Hypoxic-ischemic Encephalopathy,Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE,Infusion of hCT-MSC
158,159,NCT01463475,Graft Versus Host Disease (GVHD)|Acute Myocardial Infarction (AMI),University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol,Bone marrow aspirate
159,160,NCT02409940,Renal Transplant Rejection,To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients,Mesenchymal Stem Cells
160,161,NCT02195323,Chronic Kidney Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Intravenous injection
161,162,NCT03171194,System; Lupus Erythematosus,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Low Dose Mesenchymal Stem Cells (MSCs)
162,163,NCT02801890,Ultra Filtration Failure,Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF),Intravenous injection
163,164,NCT04466007,Limb Ischemia|Diabetic Foot,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,High dose allogeneic mesenchymal stromal cells|Low dose allogeneic mesenchymal stromal cells|Placebos
164,165,NCT03356821,Perinatal Arterial Ischemic Stroke|Neonatal Stroke,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,Mesenchymal Stem Cells
165,166,NCT03909139,Acetabular Labrum Tear|Femoro Acetabular Impingement|Chondral Defect|Bone Marrow Aspirate Concentrate|Mesenchymal Stromal Cell,Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear,BMAC
166,167,NCT02247973,Severe Aplastic Anemia,Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.,mesenchymal stem cells|mesenchymal stem cells
167,168,NCT02940418,Diabetes Mellitus Type 1,Use of Stem Cells in Diabetes Mellitus Type 1,Adipose mesenchymal cells with bone marrow mononuclear cells
168,169,NCT01840540,Atherosclerotic Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Hypertension,MSC for Occlusive Disease of the Kidney,Arterial infusion of autologous mesenchymal stem cells
169,170,NCT04247945,Allogeneic Hematopoietic Stem Cell Transplantation,Co-transplantation of MSC in the Setting of Allo-HSCT,Cotransplant with MSCs
170,171,NCT03369275,Septic Shock|Sepsis|Pathologic Processes|Shock|Infection|Systemic Inflammatory Response Syndrome|Inflammation,Cellular Immunotherapy for Septic Shock,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|Placebo
171,172,NCT02408432,Cardiomyopathy|Heart Failure,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,Laboratory Biomarker Analysis|Standard of Care|Mesenchymal Stem Cell Transplantation
172,173,NCT05060107,"Osteoarthritis, Knee",Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1),Exosomes (sEVs)
173,174,NCT03795974,"Cerebral Palsy, Spastic",Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy,MNC|MSC|Control
174,175,NCT04723303,Polymyositis|Dermatomyositis,Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM),Umbilical Cord Lining Stem Cells
175,176,NCT03258164,Breast Hypoplasia and Facial Ageing,Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts,ASC enriched lipofilling|Standard Lipofilling
176,177,NCT02962661,Cardiomyopathy|Heart Failure|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,Best Practice|Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cell Transplantation
177,178,NCT04126603,"Diabetes Mellitus, Type 2",Impact of Semaglutide on CD34+ EPC and Fat Derived MSC,Semaglutide|Placebos
178,179,NCT01624701,Acute Leukemia|Chronic Leukemia|Myelodysplastic Syndrome|Lymphoma|Myeloma,Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells,Ex vivo expanded cord blood cells
179,180,NCT03298763,Adenocarcinoma of Lung,Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer,MSCTRAIL|Placebo
180,181,NCT02209311,Partially Edentulous Maxilla|Alveolar Bone Atrophy|Alveolar Bone Loss,Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs,Oral mucosa biopsy|Sinus lift with implantation of tissue engineered construction|Dental implant
181,182,NCT04390139,COVID-19|SARS-CoV 2|Adult Respiratory Distress Syndrome,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,XCEL-UMC-BETA|Placebo
182,183,NCT05553132,Cartilage Defect,A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects,Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier
183,184,NCT02017912,Amyotrophic Lateral Sclerosis (ALS),"Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS",Autologous MSC-NTF cells|Placebo
184,185,NCT01606215,Multiple Sclerosis,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,Mesenchymal stem cells|Placebo
185,186,NCT05008588,Ischemic Stroke,Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct,Conditioned Medium|Umbilical Cord Mesenchymal Stem Cells|Neurologic and Neutrophic Drugs
186,187,NCT00908856,Stroke,Autologous Cell Therapy After Stroke,autologous bone marrow mononuclear cell transfusion|marrow stromal cells|placebo
187,188,NCT03609905,Ulcerative Colitis (UC),Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis,Adipose-cord mesenchymal stromal cells (A-MSCs)|Conventional drugs
188,189,NCT03166865,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Umbilical-cord mesenchymal stromal cells (UC-MSCs)|Hyaluronic acid
189,190,NCT03028428,Osteoarthritis|Stem Cells|MSC,Intra-articular Injection of MSCs in Treatment of Knee OA,Placenta Derived Mesenchymal Stem Cell|Sodium Hyaluronate
190,191,NCT00395200,Multiple Sclerosis,Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS),MSC Treatment
191,192,NCT01730547,Multiple Sclerosis,Mesenchymal Stem Cells for Multiple Sclerosis,Autologous mesenchymal stem cells
192,193,NCT04961658,Septic Shock,Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients,GEM00220
193,194,NCT03799718,"Multiple Sclerosis, Chronic Progressive",Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS,NurOwn (MSC-NTF cells)
194,195,NCT02685098,Ischemia|Peripheral Arterial Disease|Peripheral Vascular Disease|Vascular Disease|Arterial Occlusive Disease|Arteriosclerosis|Atherosclerosis|Cardiovascular Disease|Pathologic Processes|Orthopedic Procedures|Amputation,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Allogeneic bone marrow derived mesenchymal stem cells
195,196,NCT03847844,Acute-graft-versus-host Disease,UCMSCs as Front-line Approach of Treatment for Patients With aGVHD,Umbilical cord derived mesenchymal stem cell|Placebo
196,197,NCT04061746,"Diabetes Mellitus, Type 1",Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Mesenchymal Stem Cells (MSCs)|Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
197,198,NCT03280056,Amyotrophic Lateral Sclerosis (ALS),Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients,NurOwn® (MSC-NTF cells)|Placebo|Bone Marrow aspiration
198,199,NCT02812121,Liver Failure,UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure,umbilical cord blood mesenchymal stem cells
199,200,NCT01446614,Parkinson's Disease,Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease,bone marrow derived mesenchymal stem cells
200,201,NCT01446640,Spinal Cord Injury,Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury,bone marrow derived mesenchymal stem cells
201,202,NCT01305694,Aplastic Anemia,Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.,bone marrow derived mesenchymal stem cells
202,203,NCT04432545,Systemic Sclerosis Pulmonary|Pulmonary Hypertension|Pulmonary Fibrosis,Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement,Mesenchymal Stem Cells from Wharton ́s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ́s jelly
203,204,NCT02249676,Devic's Syndrome|Devic's Neuromyelitis Optica|Devic Syndrome|Devic's Disease|Devic Disease,Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders,Autologous mesenchymal stem cells
204,205,NCT03905824,Osteochondral Fracture of Talus,The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus,Allogenic stromal mesenchymal cells derived from the umbilical cord|Debridement and microfracture
205,206,NCT04865107,Covid19|Acute Respiratory Distress Syndrome,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,UC-MSCs|Placebo
206,207,NCT02525432,"Brain Injuries, Traumatic|Brain Injuries, Acute|TBI (Traumatic Brain Injury)",Autologous Stem Cell Study for Adult TBI (Phase 2b),Placebo Infusion|Autologous BMMNC Infusion
207,208,NCT02846883,Abdominal Aortic Aneurysm,Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms,MSCs|MSCs|Placebo
208,209,NCT03682315,Sinus Floor Augmentation,Comparison of Phicogenic vs. Xenogeneic Biomaterial for Maxillary Sinus Floor Elevation,Biphasic phycogenic biomaterial|Xenograft bovine hydroxyapatite
209,210,NCT02770430,Graft vs Host Disease,Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease,mesenchymal stem cells|conventional treatment
210,211,NCT03797963,Sinus Floor Augmentarion,Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation,PBM+ACB|ABB+ACB
211,212,NCT05152160,Graft Vs Host Disease,Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Umbilical Cord Mesenchymal Stem Cell Therapy
212,213,NCT02482194,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study,mesenchymal stem cells
213,214,NCT04602442,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,EXO 1 inhalation|EXO 2 inhalation|Placebo inhalation
214,215,NCT04491240,Covid19|SARS-CoV-2 PNEUMONIA|COVID-19,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,EXO 1 inhalation|EXO 2 inhalation|Placebo inhalation
215,216,NCT02037204,Foreign-Body Reaction|Inflammation|Effusion (L) Knee|Knee Pain Swelling,IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.,Cartilage repair surgery
216,217,NCT00731744,Normal Full-Term Deliveries,Generation of Dendritic Cell Precursors From Cord Blood Stem Cells,Normal full-term deliveries
217,218,NCT03795649,Hemorrhage,The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty,Tranexamic Acid
218,219,NCT03918655,Acute Myeloid Leukemia,MIF Involvement in AML,
219,220,NCT02696876,"Defect of Articular Cartilage|Cartilage Injury|Osteoarthritis, Knee",Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair,Arthroscopic synovial brushing|Microfracture
220,221,NCT04482699,Severe COVID-19 Disease,RAPA-501-Allo Therapy of COVID-19-ARDS,RAPA-501-Allo off-the-shelf Therapy of COVID-19|Placebo
221,222,NCT03745417,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis,Umbilical cord mesenchymal stem cells
222,223,NCT03265613,Mesenchymal Stromal Cells|Psoriasis|Drug Toxicity|Drug Effect,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,adipose-derived multipotent mesenchymal stem cells
223,224,NCT03392311,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Calcipotriol ointment|adipose-derived multipotent mesenchymal stem cells
224,225,NCT04275024,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,Calcipotriol ointment|PSORI-CM01 Granule|adipose-derived multipotent mesenchymal stem cells
225,226,NCT05086939,Knee Osteoarthritis,Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.,Autologous MSCs|Allogenic MSCs|Hyaluronic Acid
226,227,NCT02338271,Low Back Pain,Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration,autologous adipose derived mesenchymal stem cell
227,228,NCT03794622,Bone Marrow|Femoral Shaft Fracture,Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union,intramedullary nail fixation with bone marrow concentration|intramedullary nail fixation
228,229,NCT03793530,Bone Marrow|Spinal Fusion,Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery,Transforaminal lumbar interbody fusion with local bone graft and intraoperative bone marrow concentration|Transforaminal lumbar interbody fusion with local bone graft
229,230,NCT03792594,Rotator Cuff Tear|Bone Marrow,Autologous Bone Marrow Concentration for Rotator Cuff Tear,arthroscopic repair with bone marrow concentration|arthroscopic repair
230,231,NCT03787329,Avascular Necrosis of Femur|Bone Marrow,Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head,Core decompression surgery with bone marrow concentration|Core decompression surgery
231,232,NCT02240823,Delayed Graft Function,Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy,adipose derived stem cells
232,233,NCT05066334,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD,Autologous BM-MSC|Sham
233,234,NCT03103295,Bone Defects,3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects,3D-Tissue Engineered Bone Equivalent
234,235,NCT04759105,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD,Autologous BM-MSC|Sham Procedure
235,236,NCT01993368,Aggressive Periodontitis|Chronic Periodontitis,Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis,flow cytometry
236,237,NCT03369457,"Complications; Implant, Orthopedic",Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions,Isolation of multipotent cells
237,238,NCT03325322,Chronic Kidney Diseases|Diabetes Mellitus|Diabetic Nephropathies,Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease,Fisetin|Placebo oral capsule
238,239,NCT04519671,Perianal Crohn Disease|Perianal Fistula|Crohn Disease,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Mesenchymal Stem Cells|Placebo
239,240,NCT02379442,Graft-Versus-Host Disease,Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids,MSC
240,241,NCT05054803,Spinal Cord Injury Cervical,Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury,WJ-MSC (XCEL-UMC-BETA)|Placebo
241,242,NCT04785027,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,PSORI-CM01 formula|Gu Ben Hua Yu formula|adipose-derived multipotent mesenchymal stem cells
242,243,NCT04136743,Spinal Cord Injuries|Tendinopathy|Rotator Cuff Tears|Shoulder Pain,Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury,Lipogems|Dexamethasone
243,244,NCT04274543,Tibial Meniscus Injuries|Knee Injuries|Knee Injuries and Disorders,Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military,Lipogems|Normal Saline
244,245,NCT03874572,Xerostomia Due to Radiotherapy|Hyposalivation|Xerostomia|Oropharynx Cancer|Salivary Gland Diseases|Dry Mouth|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Stem Cells,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,Allogeneic adipose derived stem/stromal cells
245,246,NCT01051882,Amyotrophic Lateral Sclerosis,"Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.",MSC-NTF cells transplantation (IM)|MSC-NTF cells transplantation (IT)
246,247,NCT04461925,COVID-19 Pneumonia,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Antibiotics|Hormones|Anticoagulant Therapy|Оxygen therapy
247,248,NCT04174547,Myelodysplastic Syndromes,An European Platform for Translational Research in Myelodysplastic Syndromes,
248,249,NCT05187936,Hemophilia A|Hemophilia B|Arthropathy,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,
249,250,NCT03876197,Radiation Toxicity|Xerostomia Due to Radiotherapy|Dry Mouth|Hyposalivation|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Long Term Adverse Effects,Mesenchymal Stem Cells for Radiation-induced Xerostomia,Autologous adipose-derived mesenchymal stem/stromal cells|Placebo
250,251,NCT03555773,Crohn Disease|Perianal Fistula,Micro-fragmented Adipose Tissue and Complex Crohns' Anal Fistulas,Lipogems
251,252,NCT02619734,Chronic Leg Ulcer|Sickle Cell Disease,Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease,Infusion of Autologous Bone Marrow Mononuclear Cells
252,253,NCT04883502,Bone Loss,Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs,Blood sample collection|Other biological sample collection|Surgical waste collection|Radiological examination and functional exploration
253,254,NCT04869761,"Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus|Diabetic Nephropathies",Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion|Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions
254,255,NCT01144962,Crohn's Disease|Fistula,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,"Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.|Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection."
255,256,NCT03167138,Shoulder Pain|Shoulder Impingement Syndrome|Rotator Cuff Impingement Syndrome|Rotator Cuff Tendinitis|Rotator Cuff Syndrome of Shoulder and Allied Disorders|Spinal Cord Injuries,Micro-Fragmented Adipose Tissue (Lipogems®) Injection for Chronic Shoulder Pain in Persons With Spinal Cord Injury,Autologous micro-fragmented adipose tissue|Lipogems system
256,257,NCT01892514,Osteonecrosis,Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head,core decompression
257,258,NCT05488093,Knee Osteoarthritis,Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement,X-sens sensor
258,259,NCT03102879,Periapical Periodontitis,Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.,Regenerative Endodontic Procedure|Conventional Root Canal Treatment
259,260,NCT02448121,Avascular Necrosis of Bone|Sickle Cell Disease,Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease,Autologous bone marrow stem cell graft
260,261,NCT01777646,Amyotrophic Lateral Sclerosis,"Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)","MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF"
261,262,NCT03164083,Osteoarthritis,The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis,Mesenchymal stem cell|Placebo
262,263,NCT03840343,"Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency",Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
263,264,NCT04453111,Knee Osteoarthritis,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Placenta-derived MMSCs|Bone marrow-derived MMSCs|Hyalgan 20 mg in 2 ML Prefilled Syringe
264,265,NCT04919135,Frailty,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,Umbilical Cord Mesenchymal Stem Cells transplantation|standard frailty treatment and supplementary medication
265,266,NCT03920397,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation
266,267,NCT01849159,Pulmonary Emphysema,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Mesenchymal stem cells|Reference therapy: 400 mL of 0.9% NaCl solution
267,268,NCT02326935,Multiple Sclerosis,Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis,Autologous adipose derived mesenchymal cells
268,269,NCT02145897,Critical Limb Ischemia,To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derieved MSCs|Control
269,270,NCT00186914,Osteodysplasia,Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation,Marrow stromal cell infusion
270,271,NCT03818737,Osteoarthritis,Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES),Bone Marrow Derived MSCs|Adipose-derived MSCs|Umbilical Cord Tissue (UCT) MSCs|Corticosteroid injection
271,272,NCT05305833,Temporomandibular Joint Disorders|Temporomandibular Disorder|Temporomandibular Joint Osteoarthritis|Temporomandibular Joint Pain|Temporomandibular Joint Effusion,Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease,Stem Cells
272,273,NCT04223622,Osteoarthritis,Effects of ASC Secretome on Human Osteochondral Explants,ASC secretome
273,274,NCT02492490,Uremia,Effect of SVF Derived MSC in DCD Renal Transplantation,SVFderived MSC transplantations|Basiliximab
274,275,NCT04351932,Osteo Arthritis Knee,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis,bone marrow mesenchymal stem cells|Adipose Mesenchymal stem cells|bone marrow & adipose mesenchymal stem cells injection
275,276,NCT00781872,Multiple Sclerosis,Mesenchymal Stem Cells for the Treatment of MS,Injection of autologous bone marrow derived mesenchymal stem cells
276,277,NCT02957552,Pediatric Liver Transplantation,Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation,Mesenchymal Stem Cells
277,278,NCT04433104,COPD,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,Umbilical Cord Mesenchymal Stem Cells transplantation|drug therapy according to Vietnamese MOHS procedure
278,279,NCT02442817,Schizophrenia,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Linagliptin
279,280,NCT02135380,Idiopathic Pulmonary Fibrosis,Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derived MSCs (ADMSCs)|Control
280,281,NCT05280002,Osteoarthritis Knees,Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis,Adipose Tissue derived Total-Stromal-Cells (TOST)
281,282,NCT04821479,Amyotrophic Lateral Sclerosis,Repeated Mesenchymal Stem Cell Injections in ALS,Mesenchymal stem cells (MSC)
282,283,NCT02975960,Systemic Sclerosis,ADMSCs for the Treatment of Systemic Sclerosis,injection of autologous stromal vascular fraction
283,284,NCT02749448,Pulmonary Disease,Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients,mesenchymal stem cell
284,285,NCT05484856,"Osteoarthritis, Knee",Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA),Autologous adipose tissue derived stromal cells
285,286,NCT01548092,Recto-vaginal Fistula,Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula,Adipose-derived stem cells without expanded
286,287,NCT04340284,Nonunion of Fracture,Adipose Tissue Derived Stromal Vascular Fraction (SVF) Application in Treatment of Long Bones Nonunion,autologous adipose tissue derived stromal vascular fraction (SVF)
287,288,NCT04377334,ARDS|COVID-19,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),MSC
288,289,NCT01795950,Pulmonary Arterial Hypertension,Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH),PLX-PAD
289,290,NCT00913289,Liver Cirrhosis,Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells,adipose tissue derived stromal cells
290,291,NCT02893306,Type 1 Diabetes Mellitus,MSC Administration for the Management of Type 1 Diabetic Patients,MSCs
291,292,NCT02467387,Non-Ischemic Heart Failure,A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure,Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Lactated Ringer's Solution
292,293,NCT01062750,Liver Cirrhosis,Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells,adipose tissue derived stromal cells dosage
293,294,NCT03939741,Chronic Kidney Diseases,SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.,SVF Containg Autologous Non Expanded ADSC
294,295,NCT03601234,Gastrointestinal Stromal Tumors,Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors,laparoscopic and endoscopic cooperative surgery|laparoscopic surgery
295,296,NCT01709279,Ischemic Heart Failure,Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure,adipose tissue derived stromal cells dosage
296,297,NCT03887208,Skin|Scar|Cutis Laxa|Keloid|Cicatrix,Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells,Laser therapy|Autologous ADSC injection|Normal saline injection
297,298,NCT03042143,Acute Respiratory Distress Syndrome,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST),Human umbilical cord derived CD362 enriched MSCs|Placebo (Plasma-Lyte 148)
298,299,NCT04143048,Gastrointestinal Stromal Tumor,A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules,DNA extraction of tumer tissue samples and high-throughput sequencing of small panels|DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels|DNA extraction of tumer tissue samples and blood sample and high-throughput sequencing of small panels
299,300,NCT03726255,Perianal Fistula,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,Mesenchymal Stem Cell injection
300,301,NCT01468064,"Stroke|Infarction, Middle Cerebral Artery",Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke,Autologous BMSCs transplantation|Autologous EPCs transplantation|IV infusion of placebo
301,302,NCT01377870,Multiple Sclerosis,Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis,intravenous injection of mesenchymal stem cells|injection of cell free media
302,303,NCT04005989,Ischemic Heart Disease|Myocardial Ischemia|Coronary Artery Disease,Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization,Stromal Cells Injection
303,304,NCT02622464,Dysphonia,Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction,micro injection of SVF in vocal cords
304,305,NCT03963544,Gastro Intestinal Stromal Tumor,Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST),oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
305,306,NCT02763748,Gastrointestinal Stromal Tumor,the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor,Laparoscopic endoscopy combined surgery|laparoscopic and endoscopic cooperative surgery|Single-arch laparoscopic and endoscopic cooperative surgery
306,307,NCT05453292,Gastrointestinal Stromal Tumor (GIST),Endoscopic Ultrasound Radiofrequency Ablation for GISTs,Endoscopic ultrasound guided radiofrequency ablation
307,308,NCT04614025,COVID|ARDS,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,PLX-PAD
308,309,NCT05523011,Psoriasis,Safety and Tolerability Study of MSC Exosome Ointment,Exosome ointment
309,310,NCT01172548,Gastrointestinal Stromal Tumors,Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST),imatinib mesylate
310,311,NCT05270850,Benign Airway Stenosis|Respiratory Tract Fistula,Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Refractory Benign Airway Stenosis and Respiratory Tract Fistula,Control group|SVF group
311,312,NCT05385159,Scarred Vocal Folds,INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO,AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION|Placebo
312,313,NCT01874665,GIST,A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor,Ponatinib
313,314,NCT03109301,"Neoplasms, Nerve Tissue|Neurofibromatosis 1|Heredodegenerative Disorders, Nervous System|Peripheral Nervous System Diseases",Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST),Selumetinib (AZD6244 hyd sulfate) 50mg/dose|Selumetinib (AZD6244 hyd sulfate) 25mg/m2
314,315,NCT04269941,Gastric GIST,Prognostic Factors Affecting Survival of Gastric GIST,total or subtotal gastrectomy
315,316,NCT01557543,Heart Disease|Ischemic Heart Disease|Coronary Artery Disease|Coronary Artery Disease (CAD),Stem Cell Injection to Treat Heart Damage During Open Heart Surgery,Cell Therapy
316,317,NCT04389450,COVID|ARDS,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",PLX-PAD|Placebo
317,318,NCT05081921,Osteoarthritis of Knee,Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases,MesoCellA-Ortho administration|HA administration
318,319,NCT02492308,Living-relative Kidney Transplantation,Induction With SVF Derived MSC in Living-related Kidney Transplantation,SVF-MSC induction|Basiliximab induction
319,320,NCT01532076,Osteoporotic Fractures,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts,Cellularized composite graft augmentation|Acellular composite graft augmentation
320,321,NCT02884154,Gastrointestinal Tract|Gastrointestinal Stromal Tumor,Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors,Echotip ProCoreⓇ HD Ultrasound Biopsy Needle
321,322,NCT04314687,Cerebral Palsy,Stem Cell and Conditioned Medium for Cerebral Palsy,Umbilical Cord Mesenchymal Stem Cells|Conditioned Medium|Standard Therapy
322,323,NCT02064062,"Achilles Tendinitis, Right Leg|Achilles Tendinitis|Achilles Degeneration|Achilles Tendon Thickening|Tendinopathy|Achilles Tendinitis, Left Leg",Autologous Stem Cells in Achilles Tendinopathy,Autologous Mesenchymal Stem Cells
323,324,NCT00919958,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia,PLX-PAD IM injection
324,325,NCT00951210,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI),PLX-PAD
